Abstract

Flow cytometry, an advanced cell analysis technology, has become an integral tool in cancer research. Its ability to analyze multiple physical and chemical properties of cells at a single-cell resolution facilitates breakthroughs in biomarker discovery, tumor characterization, and personalized medicine. This article delves into the versatile applications of flow cytometry in cancer research, highlighting its contributions to biomarker discovery, understanding the tumor microenvironment, drug development, and advancing personalized therapy. Additionally, it discusses the challenges faced and explores future advancements to enhance its efficacy and accessibility in oncology.